Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Anthony L AlbistonSiew Yeen Chai

Abstract

Approximately one-quarter of people over the age of 65 are estimated to suffer some form of cognitive impairment, underscoring the need for effective cognitive-enhancing agents. Insulin-regulated aminopeptidase (IRAP) is potentially an innovative target for the development of cognitive enhancers, as its peptide inhibitors exhibit memory-enhancing effects in both normal and memory-impaired rodents. Using a homology model of the catalytic domain of IRAP and virtual screening, we have identified a class of nonpeptide, small-molecule inhibitors of IRAP. Structure-based computational development of an initial "hit" resulted in the identification of two divergent families of compounds. Subsequent medicinal chemistry performed on the highest affinity compound produced inhibitors with nanomolar affinities (K(i) 20-700 nM) for IRAP. In vivo efficacy of one of these inhibitors was demonstrated in rats with an acute dose (1 nmol in 1 microl) administered into the lateral ventricles, improving performance in both spatial working and recognition memory paradigms. We have identified a family of specific IRAP inhibitors that is biologically active which will be useful both in understanding the physiological role of IRAP and potentially in the...Continue Reading

References

Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Oct 6, 1995·The Journal of Biological Chemistry·S R KellerG E Lienhard
Mar 18, 1996·Brain Research·I MoellerS Y Chai
Sep 12, 1997·The Journal of Biological Chemistry·S B WatersK L Luskey
Jan 1, 1997·Methods in Enzymology·D EisenbergJ U Bowie
Apr 16, 1998·The American Journal of Clinical Nutrition·D L Korol, P E Gold
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·E C McNayP E Gold
Feb 15, 2001·Nature Structural Biology·M M ThunnissenJ Z Haeggström
Aug 22, 2001·Peptides·M J WaynerJ W Harding
Nov 15, 2001·The Journal of Biological Chemistry·A L AlbistonS Y Chai
Feb 20, 2003·Trends in Endocrinology and Metabolism : TEM·Anthony L AlbistonSiew Yeen Chai
Jul 23, 2003·Journal of Neurochemistry·Rebecca A LewAnthony L Albiston
Jul 29, 2004·Drug Discovery Today·Alexander HillischRolf Hilgenfeld
Nov 3, 2004·Nature Reviews. Drug Discovery·Douglas B KitchenJürgen Bajorath
Nov 19, 2004·Cellular and Molecular Life Sciences : CMLS·S Y ChaiA L Albiston
May 21, 2005·The Journal of Comparative Neurology·Ruani N FernandoSiew Yeen Chai
Dec 6, 2005·Neuroscience·S Funahashi
Feb 24, 2006·Nature Neuroscience·Sabrina DianoTamas L Horvath
Aug 4, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pramod K DashAnthony N Moore
Sep 13, 2006·Journal of Peptide Science : an Official Publication of the European Peptide Society·Andreas AxénMathias Hallberg
Mar 3, 2007·Nature Reviews. Drug Discovery·William LogingBryn Williams-Jones
Sep 29, 2007·Pharmacology & Therapeutics·Anthony L AlbistonSiew Yeen Chai
Dec 28, 2007·Progress in Neurobiology·John W WrightJoseph W Harding

❮ Previous
Next ❯

Citations

Jul 1, 2009·Der Nervenarzt·H Förstl
Apr 13, 2011·Psychopharmacology·Rasha MechaeilJennifer Rusted
Apr 27, 2012·Pflügers Archiv : European journal of physiology·John W Wright, Joseph W Harding
Apr 12, 2011·Journal of Medicinal Chemistry·Hanna AnderssonAnders Hallberg
Jan 6, 2009·BMC Neuroscience·Siew Yeen ChaiAnthony L Albiston
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Efthalia ZervoudiEfstratios Stratikos
Jan 17, 2012·Hormones and Behavior·Richard P EbsteinPoh San Lai
Jul 23, 2011·Progress in Neurobiology·John W Wright, Joseph W Harding
Dec 17, 2008·Molecular and Cellular Endocrinology·Patrick M L Vanderheyden
Mar 16, 2011·The Journal of Pharmacy and Pharmacology·Paul R GardDenis Ryan
Aug 8, 2015·Journal of Chemical Information and Modeling·Fredrik SvenssonChristian Sköld
Nov 20, 2014·Protein Science : a Publication of the Protein Society·Stefan J HermansMichael W Parker
Mar 22, 2012·European Journal of Pharmacology·Paul R GardClare Partington
Jan 11, 2013·International Journal of Hypertension·Hanna Andersson, Mathias Hallberg
Apr 15, 2016·Assay and Drug Development Technologies·Karin EngenMats Larhed
Feb 11, 2015·Nature Reviews. Endocrinology·Cesar A RomeroMatthew R Weir
Dec 3, 2014·Progress in Neurobiology·John W WrightJoseph W Harding
Dec 3, 2014·Progress in Neurobiology·Froylan Vargas-MartínezIsmael Jiménez-Estrada
May 7, 2016·Nucleic Acids Research·Douglas E V Pires, David B Ascher
Nov 5, 2016·Neurobiology of Learning and Memory·Holly R YeatmanSiew Yeen Chai
Jan 12, 2017·The FEBS Journal·Nyssa DrinkwaterSheena McGowan
Mar 31, 2017·Journal of Molecular Endocrinology·Anthony L AlbistonSiew Yeen Chai
Apr 8, 2017·Journal of Alzheimer's Disease : JAD·Patrick Gavin KehoeJ Scott Miners
Jun 14, 2017·Medicinal Research Reviews·Mathias HallbergAnders Hallberg
May 12, 2017·Expert Opinion on Drug Discovery·Amanda T S AlbanazDavid B Ascher
Apr 15, 2017·Biochemical Society Transactions·Arun Prasad PanduranganTom L Blundell
May 8, 2009·Journal of Computational Chemistry·Imran S Haque, Vijay S Pande
Apr 17, 2013·Physiological Reviews·Mark D Parker, Walter F Boron
Jan 6, 2015·ChemistryOpen·Sanjay R BorhadeMathias Hallberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.